Laura Ochoa-Callejero

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Atrial Fibrillation

Brain Metastases

Cardiovascular Risk Factors

Top Venues

Current issues in molecular biology

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Francisco José Julián-Villaverde, Marta Serrano-Ponz, Enrique Ramalle-Gómara, Alfredo Martínez, Laura Ochoa-Callejero
CCL5 Levels Predict Stroke Volume Growth in Acute Ischemic Stroke and Significantly Diminish in Hemorrhagic Stroke Patients. International journal of molecular sciences 23 (17) (2022)
Laura Ochoa-Callejero, Josune García-Sanmartín, Pablo Villoslada-Blanco, María Íñiguez, Patricia Pérez-Matute, Elisabet Pujadas, Mary E Fowkes, Rachel Brody, José Antonio Oteo, Alfredo Martínez
Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients. Journal of the Endocrine Society 5 (3) (2021)
Francisco J Julián-Villaverde, Laura Ochoa-Callejero, Eva Siles, Esther Martínez-Lara, Alfredo Martínez
Adrenomedullin Is a Diagnostic and Prognostic Biomarker for Acute Intracerebral Hemorrhage. Current issues in molecular biology 43 (1) (2021)
Adam M Passman, Robyn P Strauss, Sarah B McSpadden, Megan Finch-Edmondson, Neil Andrewartha, Ken H Woo, Luke A Diepeveen, Weihao Zhao, Joaquín Fernández-Irigoyen, Enrique Santamaria, Laura Medina-Ruiz, Martyna Szpakowska, Andy Chevigné, Hyerin Park, Rodrigo Carlessi, Janina E E Tirnitz-Parker, José-Ramon Blanco, Roslyn London, Bernard A Callus, Caryn L Elsegood, Murray V Baker, Alfredo Martínez, George C T Yeoh, Laura Ochoa-Callejero
Maraviroc Prevents HCC Development by Suppressing Macrophages and the Liver Progenitor Cell Response in a Murine Chronic Liver Disease Model. Cancers 13 (19) (2021)
Marcos Vilariño, Josune García-Sanmartín, Laura Ochoa-Callejero, Alberto López-Rodríguez, Jaime Blanco-Urgoiti, Alfredo Martínez
Macrocybin, a Natural Mushroom Triglyceride, Reduces Tumor Growth In Vitro and In Vivo through Caveolin-Mediated Interference with the Actin Cytoskeleton. Molecules (Basel, Switzerland) 25 (24) (2020)